Expand ARTV Menu
ARTV MENU

ARTV Latest Press Releases

-- July 17, 2026 --

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- June 23, 2026 --

Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Globe Newswire 4:05 PM

-- June 8, 2026 --

Artiva Biotherapeutics Highlights AlloNK Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today Globe Newswire 6:30 AM

-- May 28, 2026 --

Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

-- May 19, 2026 --

Artiva Biotherapeutics Announces Multiple AlloNK Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases Globe Newswire 4:05 PM
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development Globe Newswire 8:00 AM

-- May 8, 2026 --

Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants Globe Newswire 6:52 AM
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 6:31 AM
Artiva Announces Positive Initial Clinical Data with AlloNK Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026 Globe Newswire 6:30 AM

-- April 8, 2026 --

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference Globe Newswire 8:00 AM

-- March 10, 2026 --

Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes